MedPath

Pneumotil Tilmicosin 20%w/w Powder

Registration Number: MAL14120196HA

Approved
Approval ID

c9ffbc7cbd68e7bc

Registration Number

MAL14120196HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

20.00 mcg/mLAvailable
Package Size: 20.00 mcg/mL
Status: NPRA Approved
1.00 mcg/mLAvailable
Package Size: 1.00 mcg/mL
Status: NPRA Approved
5.00 mcg/mLAvailable
Package Size: 5.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TILMICOSIN PHOSPHATEActive
Monograph: tilmicosin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.